⌘K
Loading ticker…
DexCom, Inc. · Healthcare · Medical Equipment
As of 2026-06-26, DexCom, Inc. (DXCM) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.6%, relative volume 1.24×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
52 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
DXCM is in a stage 1 base, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 4.4% / 4.3%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
DXCM is held by 23 ETFs as of Mar 2026. Top owner: VTI at 0.04% weight, $768M notional. Top 3 carry $1.9B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.04% | $768M |
| VOOVanguard S&P 500 ETF | 0.04% | $614M |
| VOVanguard Mid-Cap ETF | 0.26% | $522M |
| QQQInvesco QQQ Trust Series I | 0.14% | $509M |
| IVViShares Core S&P 500 ETF | 0.04% | $311M |
| VUGVanguard Growth ETF | 0.10% | $305M |
| SPYState Street SPDR S&P 500 ETF | 0.04% | $280M |
| VOTVanguard Mid-Cap Growth ETF | 0.63% | $184M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.46% | $176M |
| IWFiShares Russell 1000 Growth ETF | 0.09% | $99M |
Showing 10 of 23 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DXCM Jan avg: 3.52% median: 3.92% win: 50% σ: 8.60% n: 4 2022-04-12 → 2026-05-29 | DXCM Feb avg: 0.20% median: 1.15% win: 75% σ: 3.81% n: 4 2022-04-12 → 2026-05-29 | DXCM Mar avg: -3.00% median: -4.91% win: 50% σ: 19.44% n: 4 2022-04-12 → 2026-05-29 | DXCM Apr avg: -4.28% median: -5.17% win: 40% σ: 9.11% n: 5 2022-04-12 → 2026-05-29 | DXCM May avg: 1.36% median: -3.36% win: 40% σ: 20.96% n: 5 2022-04-12 → 2026-05-29 | DXCM Jun avg: 1.71% median: 0.90% win: 75% σ: 5.89% n: 4 2022-04-12 → 2026-05-29 (current) | DXCM Jul avg: -10.15% median: -5.27% win: 25% σ: 21.37% n: 4 2022-04-12 → 2026-05-29 | DXCM Aug avg: -5.81% median: -3.28% win: 50% σ: 9.55% n: 4 2022-04-12 → 2026-05-29 | DXCM Sep avg: -5.91% median: -5.46% win: 0% σ: 3.98% n: 4 2022-04-12 → 2026-05-29 | DXCM Oct avg: 9.21% median: 0.17% win: 50% σ: 28.21% n: 4 2022-04-12 → 2026-05-29 | DXCM Nov avg: 11.50% median: 9.84% win: 75% σ: 13.94% n: 4 2022-04-12 → 2026-05-29 | DXCM Dec avg: 2.27% median: 2.14% win: 50% σ: 4.55% n: 4 2022-04-12 → 2026-05-29 |